Using urine to study immune responses to chlamydia
Official title: Using Urine to Study Antibodies & Functional Cell-Mediated Immunity in the Context of Chlamydia Trachomatis
Run by Universiteit Antwerpen · NCT07596316 · Data updated 2026-11-12
This study tests whether first-void urine and self-collected vaginal swabs can reveal immune signals against Chlamydia trachomatis in adult women who test positive.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 73 (estimated) |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 1 site (Antwerp, Antwerp) |
| Status | Recruiting |
| Started | December 10, 2025 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT07596316 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women with a CT-positive vaginal sample or first-void urine, who can self-collect specimens and provide informed consent.
✕Probably not a fit
Individuals not able to provide self-collected samples or who have conditions that confound immune measurements may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores non-invasive samples collected by participants to detect mucosal and systemic immune responses to Chlamydia trachomatis. Researchers will compare CT-specific antibodies and cellular responses in urine and vaginal samples with blood samples, aiming to assess feasibility and concordance. The study also investigates how local genital tract immunity relates to systemic immunity. Eligible participants are adult women with CT-positive samples who consent to self-collection and an in-clinic blood draw and questionnaire completion.
Why it matters
Potential benefit: If successful, the approach could enable easier, person-friendly monitoring of CT immune responses without invasive blood draws.
How similar studies have gone: Preliminary work suggests urine and vaginal samples can reflect mucosal immune activity, but standardized methods are not yet established, making this pilot important.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female * Chlamydia trachomatis NAAT positive vaginal sample or first-void urine sample. * Able to understand the information brochure and what the study is about. * Willing to give informed consent to use their samples for details described in the study protocol. Exclusion Criteria: * Pregnancy (self-reported) * Being positive for Human Immunodeficiency Virus (HIV) * Women that underwent hysterectomy. * Menstruation at the time of sample collection. * Current use of antibiotics effective against Chlamydia trachomatis (doxycyline or azithromycine) or use of such antimicrobials in the past 14 days before participating in the study. * Participating in another clinical trial at the same time of participating in this study. * Having a history or current evidence of any condition or abnormality that might confound the results of the study or is not in the best interest of the individual to participate, in the opinion of the investigator.
Where it's running
-
Violett Antwerp
Antwerp, Antwerp, Belgium Recruiting
Study contacts
- Study coordinator: Anne Van Caesbroeck
- Email: anne.vancaesbroeck@uantwerpen.be
- Phone: +32 476 01 48 43
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
Movement improves balance and touch in older adults with type 2 diabetes
This study tests whether a 12-week exercise program, with or without extra balance training, can improve balance for people 60 and older with type 2 diabetes.
-
Prevalence and possible role of non-H. pylori Helicobacter species in gastric conditions and cancers
Researchers will test stomach tissue from people with functional dyspeasia, various gastritis conditions, gastric cancer, and bariatric patients to see if non-H. pylori Helicobacter species are present.
-
Boosted compression for lower limb edema
This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.
-
First-void urine collection device: try and refine instructions and usability
We’re testing a new first-void urine collection device to see if the instructions are clear and the device is easy to use for people who have not used it before.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.